<< View All Contributors
Debi Fischer is a nurse at the University of Miami surgical oncology step down unit. Prior to that she worked in orthopedics and neurology for many years. In addition to her nursing experience, she has earned a master’s degree in social work. Becoming a Licensed Clinical Social Worker was a lon-sought-after goal which she finally attained. She is a caregiver for her family and her dogs as well.

Prepectoral Implants: An Emerging Breast Reconstruction Solution

A study published in the journal Plastic and Reconstructive Surgery described a surgical procedure called prepectoral breast reconstruction that was used among patients who had mastectomies and radiation therapy following their breast cancer diagnosis.
PUBLISHED: 1:00 PM, SAT DECEMBER 1, 2018
As a nurse in surgical oncology, I have worked with patients recovering from mastectomies who have had to make decisions about whether to have breast reconstruction surgery. There are a variety of options to choose from.

A study published in the journal Plastic and Reconstructive Surgery, conducted by Hani Sbitany, MD, associate professor of plastic and reconstructive surgery at the University of California, San Francisco, described a surgical procedure, called prepectoral breast reconstruction, that was used among patients who had mastectomies and radiation therapy following their breast cancer diagnosis.1

This procedure is an option that oncology nurses can familiarize themselves with for their existing or future patients with breast cancer. It has been my experience that non-OR nurses are not always aware of surgical techniques that have changed. However, increasing knowledge of different surgical procedures will benefit patients in the long run. 

Benefits of Using Prepectoral Implants

Prepectoral breast reconstruction is a procedure in which implants are positioned on top of the muscle and supported by a biological mesh product called an acellular dermal matrix. Patients benefit from this procedure in several ways: There is less pain compared with under-the-muscle procedures; it eliminates animation deformity; and it results in higher patient satisfaction, according to the study.  In addition, this procedure can preserve the pectoralis major muscle and chest wall function.1

Selection of Patients

Patients with existing submuscular breast implants who had their surgeries done 5 to 15 years ago may be eligible for this procedure.

In addition, by “routine use of oversizing implants in the skin envelope, careful selection of full capacity or cohesive gel implants, and autologous fat grafting,” women at different stages of postoperative care can have this surgery.1 This includes those opting to have reconstruction right after mastectomy as well as those having the surgery later, as part of a 2-stage tissue expander-based reconstruction. 

The surgeon must consider several factors before proceeding with prepectoral breast reconstruction. Specific criteria for not proceeding with this surgery involves a malignancy that “invades the chest wall or comes to within 0.5 cm of the pectoralis major muscle.”1 Patients with this type of tumor have potential for a larger risk of recurrence.1  Also, it is unsuitable for candidates with inflammatory breast cancer, stage IV disease, and strong axillary metastasis.1 

Diabetes with poor control, as well as being classified as obese, with a BMI of more than 35 is deemed a contraindication to this surgery. Smoking, either currently or in the recent past, are also terms for exclusion as it concerns the vascular status of the patient.

Downsides

Circulation that is not of optimal quality sets the stage for “poor soft-tissue quality, thus increasing the risk of skin flap necrosis and extrusion or infection of the prosthesis.”1 Women who have previously undergone radiation to the affected breast are at risk of wound problems such as dehiscence with this technique.1 And lastly, infection is another concern. 

In addition to medical concerns, the mesh is expensive, and insurance may not cover it. It has been suggested that this new acellular dermal matrix may raise the price to double that of traditional reconstructive surgery.2   

To further evaluate this procedure, Sbitany, who also consults for Allergan–the producer of the mesh–has been conducting a study (to be published in the journal Plastic and Reconstructive Surgery in early 2019) using feedback from patients who have chosen to receive prepectoral implants.
 
References
  1. Hani S. Important considerations for performing prepectoral breast reconstruction. Plast Reconstr Surg. 2017;140:7S–13S. doi:10.1097/PRS.0000000000004045.
  2. Rabin RC. New approach to breast reconstruction may reduce pain and weakness for some. The New York Times. nytimes.com/2018/09/17/well/live/breast-reconstruction-implants-muscle.html. Published September 17, 2018. Accessed November 29, 2018.

 



 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
More from Debi Fischer, MSW, BSN, BA, LCSW, RN
Elise James, LCSW, and Mayra Garcia, LCSW, describe the Stem Cell Transplant Meet and Greet program at The Sylvester Comprehensive Cancer Center, which provides psychosocial support to pre-transplant patients. 
PUBLISHED: Tue November 13 2018
An 11-year study showed that patients with nonmetastatic breast cancer who learned to manage their stress with cognitive behavioral interventions had less depression and a better quality of life.
PUBLISHED: Thu November 08 2018
Elderly women living in nursing homes who were diagnosed with breast cancer may face a greater chance of death compared with their non-resident peers–despite what, for many in other age groups, is routine surgery. Therefore, the decision to perform breast cancer surgery must lie with the patient, family, and her physician. 
PUBLISHED: Tue November 06 2018
Patient education comes in many forms. Consider the podcast.
PUBLISHED: Thu October 18 2018
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.